OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Progresses in biomarkers for cancer immunotherapy
Xuwen Lin, Chenyu Zong, Zhihan Zhang, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 15
Xuwen Lin, Chenyu Zong, Zhihan Zhang, et al.
MedComm (2023) Vol. 4, Iss. 5
Open Access | Times Cited: 15
Showing 15 citing articles:
Modulating gut microbiome in cancer immunotherapy: Harnessing microbes to enhance treatment efficacy
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 25
Xing Kang, Harry Cheuk-Hay Lau, Jun Yu
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101478-101478
Open Access | Times Cited: 25
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
RNA modification gene WDR4 facilitates tumor progression and immunotherapy resistance in breast cancer
Yongzhou Luo, W. H. Tian, Da Kang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 6
Yongzhou Luo, W. H. Tian, Da Kang, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 6
Application of immune checkpoint inhibitors for resectable gastric/gastroesophageal cancer
Feizhi Lin, Yongming Chen, Bowen Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Feizhi Lin, Yongming Chen, Bowen Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Circulating Cancer-Associated Macrophage-like Cells as a Blood-Based Biomarker of Response to Immune Checkpoint Inhibitors
Valentina Magri, Gianluigi De Renzi, Luca Marino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3752-3752
Open Access | Times Cited: 1
Valentina Magri, Gianluigi De Renzi, Luca Marino, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 7, pp. 3752-3752
Open Access | Times Cited: 1
A single-cell perspective on immunotherapy for pancreatic cancer: from microenvironment analysis to therapeutic strategy innovation
Rui Wang, Jie Liu, Bo Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Rui Wang, Jie Liu, Bo Jiang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Exploring GZMK as a Prognostic Marker and Predictor of Immunotherapy Response in Breast Cancer: Unveiling Novel Insights into Treatment Outcomes
Zitao Li, Qiqi Xie, Fuxing Zhao, et al.
Research Square (Research Square) (2024)
Open Access
Zitao Li, Qiqi Xie, Fuxing Zhao, et al.
Research Square (Research Square) (2024)
Open Access
ARHGAP44 gene: a cytoskeleton mobility related modulator with potential implication in pan-cancer prognosis risk prediction and immune regulation
Ningning Shen, Huijun Yang, Xuzhi Wang, et al.
Research Square (Research Square) (2024)
Open Access
Ningning Shen, Huijun Yang, Xuzhi Wang, et al.
Research Square (Research Square) (2024)
Open Access
Exploring GZMK as a prognostic marker and predictor of immunotherapy response in breast cancer: unveiling novel insights into treatment outcomes
Zitao Li, Qiqi Xie, Fuxing Zhao, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access
Zitao Li, Qiqi Xie, Fuxing Zhao, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 6
Open Access
SLITRK2 as a Prognostic and Immunological Biomarker in Gastric Cancer
huiqiong zhu, Hailin Xiong, Xuli Guo, et al.
Research Square (Research Square) (2024)
Closed Access
huiqiong zhu, Hailin Xiong, Xuli Guo, et al.
Research Square (Research Square) (2024)
Closed Access
Reduced intestinal‐to‐diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinoma
Lei Wang, Linghong Wan, Xu Chen, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access
Lei Wang, Linghong Wan, Xu Chen, et al.
MedComm (2024) Vol. 5, Iss. 11
Open Access
SLITRK2 as a prognostic and immunological biomarker in gastric cancer
Huiqiong Zhu, Hailin Xiong, Xuli Guo, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Huiqiong Zhu, Hailin Xiong, Xuli Guo, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Immune Biomarkers and Predictive Signatures in Gastric Cancer: Optimizing Immunotherapy Responses
Sundaram Vickram, Shofia Saghya Infant, S. Manikandan, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155743-155743
Closed Access
Sundaram Vickram, Shofia Saghya Infant, S. Manikandan, et al.
Pathology - Research and Practice (2024) Vol. 265, pp. 155743-155743
Closed Access
Physiological markers for immunotherapeutics: a review
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Journal of Chemotherapy (2024), pp. 1-24
Closed Access
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Journal of Chemotherapy (2024), pp. 1-24
Closed Access
Pan-cancer Analysis of a Cytoskeleton Mobility related ARHGAP44 gene with Potential Implications in Cancer Prognosis Risk Prediction and Immune Landscape Modulation
Ningning Shen, Huijun Yang, Xuzhi Wang, et al.
Research Square (Research Square) (2023)
Open Access
Ningning Shen, Huijun Yang, Xuzhi Wang, et al.
Research Square (Research Square) (2023)
Open Access
